CVE-2022-38802
Published: 30 November 2022
Summary
CVE-2022-38802 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Zkteco Biotime. Its CVSS base score is 6.2 (Medium).
Operationally, ranked in the top 31.1% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2022-41362
Vulnerability details
Zkteco BioTime < 8.5.3 Build:20200816.447 is vulnerable to Incorrect Access Control via resign, private message, manual log, time interval, attshift, and holiday. An authenticated administrator can read local files by exploiting XSS into a pdf generator when exporting data as…
more
a PDF
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.